Cancer Incidence & Projection
Cancer incidence is rising globally, with the number of new cases projected to nearly double by 2050 compared to 2025 (WHO International Agency for Research on Cancer). In this context, I have explored the financial landscape of genomic sequencing in oncology, with a particular emphasis on Europe.
While sequencing may not always be pivotal for initial diagnosis, it plays a critical role in guiding therapeutic decision-making and treatment stratification. I have a strong personal interest in colorectal and lung cancer subtypes, due to their incidence on the maternal side of my family originating from Goa, which forced me to a prolonged career break. Such experience, however, has given me a detailed understanding of the key biomarkers and current therapeutic lines for these cancers.
